Key result
The Freedom SOLO aortic valve demonstrated good early and intermediate-term results, with a 3% hospital mortality, 97% 1-year survival, and improved transvalvular gradients.
Cohort (n=100)
No
The Freedom SOLO stentless aortic valve demonstrates excellent early and intermediate-term haemodynamic performance and high 1-year survival in an older, high-risk patient cohort.
No takes yet. Share an insight, caveat, or question.
May support consideration in high-risk patients; leaves open randomized trials for durability and outcomes.
Oses et al. (2010) conducted a cohort in Aortic valve disease requiring replacement (n=100). Freedom SOLO aortic valve was evaluated on Postoperative and intermediate-term haemodynamic results and survival. The Freedom SOLO aortic valve demonstrated good early and intermediate-term results, with a 3% hospital mortality, 97% 1-year survival, and improved transvalvular gradients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: